MOESM9 of Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis

Hanlon, Peter; Hannigan, Laurie; Rodriguez-Perez, Jesus; Fischbacher, Colin; Welton, Nicky; Dias, Sofia; Mair, Frances; Guthrie, Bruce; Wild, Sarah; McAllister, David

doi:10.6084/m9.figshare.10288206.v1

12916_2019_1427_MOESM9_ESM.pdf (159.35 kB)

MOESM9 of Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis

journal contribution

posted on 2019-11-12, 05:04 authored by Peter Hanlon, Laurie Hannigan, Jesus Rodriguez-Perez, Colin Fischbacher, Nicky Welton, Sofia Dias, Frances Mair, Bruce Guthrie, Sarah Wild, David McAllister

Additional file 9. Proportion-with-each-comorbidity-for-trials-and-sail.pdf: Analysis of the prevalence of each comorbidity, within each index condition, in trial participants and the community sample.

Funding

Wellcome Trust

History

Usage metrics

Keywords

Randomised controlled trials Comorbidity Multimorbidity

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

MOESM9 of Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis

Funding

Wellcome Trust

History

Usage metrics

Categories

Keywords

Licence

Exports